Watts-Oquendo, Erika T. published the artcileEffect of topical pramoxine hydrochloride on discomfort, wheal and flare associated with epicutaneous allergy test, Application of 4-(3-(4-Butoxyphenoxy)propyl)morpholine hydrochloride, the publication is Annals of Allergy, Asthma, & Immunology (2019), 122(6), 652-653, database is CAplus and MEDLINE.
Thus, our results about treatment effect cannot be extrapolated to children or men. Future studies in children, using more antigens and intradermal test, are warranted based on these results. We report that topical pramoxine does not affect wheal and flare response to allergens nor histamine control and can be used in subjects with hyperalgesia to reduce discomfort associated with the skin test procedure.
Annals of Allergy, Asthma, & Immunology published new progress about 637-58-1. 637-58-1 belongs to ethers-buliding-blocks, auxiliary class Inhibitor, name is 4-(3-(4-Butoxyphenoxy)propyl)morpholine hydrochloride, and the molecular formula is C14H26O2, Application of 4-(3-(4-Butoxyphenoxy)propyl)morpholine hydrochloride.
Referemce:
https://en.wikipedia.org/wiki/Ether,
Ether | (C2H5)2O – PubChem